Intraoperative Mapping of Regional Lymphatics Draining the Primary Site of Melanoma Using Isosulfan Blue

Completed

Conditions studied: Melanoma

In brief

The purpose of this study is to determine whether we can consistently identify the first lymph node (the "sentinel node") draining your melanoma.

Key facts

Study ID

NCT00581698

Run by

Memorial Sloan Kettering Cancer Center

People needed

876

Starts

1991-01-01

Expected to finish

2009-09-01

Last updated by the study team

2009-09-15

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• primary melanomas Clark III and Breslow thickness > 1 mm, or Clark IV-V and any Breslow thickness
• clinically negative regional nodes

You may not qualify if…

• previous definitive wide local excision of the primary melanoma with skin graft
• an inflammatory lesion in the area of the primary melanoma that is likely to drain to the same nodal basin
• pregnancy

Where it is running

• Memorial Sloan-Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.